End-of-life care accounts for a good deal of total health care spending and Medicare obviously pays for a lot of that end-of-life care. A research letter in JAMA Internal Medicine analyzes whether the slowdown in Medicare fee-for-service spending is in part due to any reduction in the costs of end-of-life care. (JAMA Int. Med. Article) The authors used constant dollar spending data from 2004 to 2014 to evaluate the spending on people who died in the two years prior to death. Per beneficiary Medicare expenditures went from $9119 in 2004 to $10458 in 2009 to $9589 in 2014. Much of the recent decline is attributable to lower per capita spending on decedents and this decrease is driven by lower intensity of service. Inpatient, physician and home health service cost reductions were the major sources of lower spending, with inpatient making a particularly notable contribution, suggesting that more people are avoiding intensive hospital stays when enduring a critical illness near the end-of-life. Among all beneficiaries, per capita home health spending rose during the period, while it stayed relatively flat for decedents, indicating that this troublesome category was better managed for those near death. Hospital outpatient spending was also more restrained for decedents than for the total population. The study suggests that efforts to rein in use of expensive care in futile situations may be having an effect.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 19, 2024
Another Body Blow to Gender Dis-Affirmation
A review from Britain reveals the complete lack of any scientific evidence to support the…
Commentary
April 18, 2024
Progress Against Cancer
The US has made particularly good progress in treating cancer and limiting mortality, but much…
Commentary
April 17, 2024
I Am Done With Coronamonomania, Part 4, Vax Safety Edition
A somewhat lengthy examination of recent studies related mostly to vax safety, the results of…